舒尔KSE1200静电耳机系统
静电耳机提供了无与伦比的音质,但它往往围绕着一对笨重的耳机和专用的扩音器限制了他们的移动性。这款舒尔的全新KSE1200s具有单一驱动器的静电力,可以在不受线圈或硬锥体干扰的情况下发出声音,以获得其他便携式播放器无法获得的清晰度和细节。隔音耳机还带有高压扩音器,可以用于数模转换,并与高级音频播放器无缝集成。
静电耳机提供了无与伦比的音质,但它往往围绕着一对笨重的耳机和专用的扩音器限制了他们的移动性。这款舒尔的全新KSE1200s具有单一驱动器的静电力,可以在不受线圈或硬锥体干扰的情况下发出声音,以获得其他便携式播放器无法获得的清晰度和细节。隔音耳机还带有高压扩音器,可以用于数模转换,并与高级音频播放器无缝集成。
HairMax's LaserBand 272 brings clinical hair-growth technology into a form factor designed for convenience, combining 272 medical-grade lasers with a flexible, hands-free design that treats the entire scalp in as little as 90 seconds per session. Using low-level laser therapy to stimulate hair follicles and promote healthier, denser-looking hair, the device offers a non-invasive approach for men and women seeking to address thinning without adding another complicated step to the routine. The patented band design parts the hair automatically to maximize laser delivery, while its cordless operation keeps the process refreshingly simple. More than a grooming gadget, the LaserBand 272 represents a high-tech approach to hair restoration that prioritizes speed and ease alongside proven light-based therapy.
Presented by Hairmax.
Arbor makes physician-prescribed GLP-1 weight loss treatment more accessible with transparent pricing that stays put, even as doses change. Plans start at $99/month for compounded semaglutide and $149/month for compounded tirzepatide, with no insurance, hidden fees, or membership costs required. The telehealth platform connects patients with licensed U.S. clinicians through a simple online assessment, with eligible prescriptions shipped free and each subscription covering medication, consultations, dose adjustments, and ongoing support. Board-certified physicians, dietitian-led nutrition guidance, and a 12-month money-back guarantee for eligible members round out a program designed to make medically supervised weight management simpler and more affordable.
Presented by Arbor.
Arbor is a technology platform; medical evaluations are conducted by independent licensed providers who determine whether treatment is appropriate. Compounded medications are not reviewed by the FDA for safety or effectiveness. Consultation requirements vary by state.